RAY B Stock Overview
RaySearch Laboratories AB (publ), empresa de tecnología médica, desarrolla soluciones informáticas para el tratamiento del cáncer en Asia-Pacífico, Oriente Medio, América, Europa y África.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for RAY B from our risk checks.
RaySearch Laboratories AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr120.20 |
| 52 Week High | kr121.40 |
| 52 Week Low | kr55.60 |
| Beta | 1.23 |
| 1 Month Change | 13.83% |
| 3 Month Change | 37.84% |
| 1 Year Change | 55.30% |
| 3 Year Change | 30.51% |
| 5 Year Change | 12.86% |
| Change since IPO | 21,112.01% |
Recent News & Updates
Recent updates
RaySearch Laboratories (STO:RAY B) Will Want To Turn Around Its Return Trends
Oct 04
Does RaySearch Laboratories (STO:RAY B) Have A Healthy Balance Sheet?
Jul 10Is RaySearch Laboratories (STO:RAY B) Using Too Much Debt?
Nov 17One Forecaster Is Now More Bearish On RaySearch Laboratories AB (publ) (STO:RAY B) Than They Used To Be
Mar 15Is RaySearch Laboratories (STO:RAY B) A Risky Investment?
Feb 22Is RaySearch Laboratories (STO:RAY B) Using Debt In A Risky Way?
Nov 04Is RaySearch Laboratories (STO:RAY B) Using Debt In A Risky Way?
Mar 30What Kind Of Shareholders Hold The Majority In RaySearch Laboratories AB (publ)'s (STO:RAY B) Shares?
Feb 23RaySearch Laboratories' (STO:RAY B) Shareholders Are Down 41% On Their Shares
Feb 02RaySearch Laboratories AB (publ)'s (STO:RAY B) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 13
These 4 Measures Indicate That RaySearch Laboratories (STO:RAY B) Is Using Debt Reasonably Well
Dec 26Shareholder Returns
| RAY B | SE Healthcare Services | SE Market | |
|---|---|---|---|
| 7D | 4.5% | -0.07% | -0.002% |
| 1Y | 55.3% | 21.8% | 13.9% |
Rentabilidad frente al sector: RAY B superó al sector Swedish Healthcare Services , que obtuvo un rendimiento del 34.7% el año pasado.
Rentabilidad vs. Mercado: RAY B superó al mercado Swedish, que obtuvo un rendimiento del 4.8% el año pasado.
Price Volatility
| RAY B volatility | |
|---|---|
| RAY B Average Weekly Movement | 5.0% |
| Healthcare Services Industry Average Movement | 6.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in SE Market | 13.1% |
| 10% least volatile stocks in SE Market | 3.5% |
Precio estable de las acciones: El precio de las acciones de RAY B ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de RAY B (4%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 388 | Johan Lof | https://www.raysearchlabs.com |
RaySearch Laboratories AB (publ), empresa de tecnología médica, desarrolla soluciones de software para el tratamiento del cáncer en Asia-Pacífico, Oriente Medio, América, Europa y África. Desarrolla y comercializa RayStation, un sistema de planificación de tratamientos; RayPlan, un sistema de planificación de tratamientos para apoyar una serie de actividades de planificación de tratamientos para 3D-CRT, IMRT, VMAT, tomoterapia y radioterapia de haz de electrones; y RayCare, una información oncológica. Además, ofrece µ-RayStation, una plataforma de software para la planificación y evaluación en la investigación de la irradiación de pequeños animales; RayCommand, un sistema de control del tratamiento que sirve de enlace entre la máquina de tratamiento y los sistemas de planificación del tratamiento y de información oncológica; y RayIntelligence, un sistema de análisis oncológico basado en la nube que convierte los datos de los pacientes en información.
RaySearch Laboratories AB (publ) Fundamentals Summary
| RAY B fundamental statistics | |
|---|---|
| Market cap | kr4.12b |
| Earnings (TTM) | kr81.57m |
| Revenue (TTM) | kr1.02b |
50.5x
P/E Ratio4.0x
P/S RatioIs RAY B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RAY B income statement (TTM) | |
|---|---|
| Revenue | kr1.02b |
| Cost of Revenue | kr106.58m |
| Gross Profit | kr915.58m |
| Other Expenses | kr834.01m |
| Earnings | kr81.57m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | 2.38 |
| Gross Margin | 89.57% |
| Net Profit Margin | 7.98% |
| Debt/Equity Ratio | 0.1% |
How did RAY B perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield29%
Payout RatioDoes RAY B pay a reliable dividends?
See RAY B dividend history and benchmarks| RaySearch Laboratories dividend dates | |
|---|---|
| Ex Dividend Date | May 23 2024 |
| Dividend Pay Date | May 29 2024 |
| Days until Ex dividend | 47 days |
| Days until Dividend pay date | 53 days |
Does RAY B pay a reliable dividends?
See RAY B dividend history and benchmarks